These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 10506692

  • 1. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Taamma A, Fandi A, Azli N, Wibault P, Chouaki N, Hasbini A, Couteau C, Armand JP, Cvitkovic E.
    Cancer; 1999 Oct 01; 86(7):1101-8. PubMed ID: 10506692
    [Abstract] [Full Text] [Related]

  • 2. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N, Fandi A, Bachouchi M, Rahal M, Lianes P, Wibault P, Boussen H, Eschwege F, Armand JP, Cvitkovic E.
    Cancer J Sci Am; 1995 Oct 01; 1(3):222-9. PubMed ID: 9166480
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.
    Hasbini A, Mahjoubi R, Fandi A, Chouaki N, Taamma A, Lianes P, Cortès-Funes H, Alonso S, Armand JP, Cvitkovic E, Raymond E.
    Ann Oncol; 1999 Apr 01; 10(4):421-5. PubMed ID: 10370784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.
    Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, Eschwege F, Armand JP, Simon J, Cvitkovic E.
    J Clin Oncol; 2000 Mar 01; 18(6):1324-30. PubMed ID: 10715304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
    Tellez-Bernal E, Belehradek M, Recondo G, Cvitkovic E, Leridant AM, Vericel R, Armand JP.
    Am J Clin Oncol; 1990 Oct 01; 13(5):452-4. PubMed ID: 1699403
    [Abstract] [Full Text] [Related]

  • 18. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).
    Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H.
    Ann Oncol; 1994 Sep 01; 5(7):609-16. PubMed ID: 7993836
    [Abstract] [Full Text] [Related]

  • 19. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in locally advanced or metastatic gastric cancer: a single institution experience.
    Aitini E, Rabbi C, Mambrini A, Cavazzini G, Pari F, Zamagni D, Cantore M, Pagani M, Sorio M, Lusenti A, Adami F, Smerieri F.
    Tumori; 2001 Sep 01; 87(1):20-4. PubMed ID: 11669552
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.